Your browser doesn't support javascript.
loading
Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.
Cardiovasc Diabetol ; 14: 31, 2015 Mar 10.
Article in En | MEDLINE | ID: mdl-25848912

Full text: 1 Database: MEDLINE Main subject: Vascular Diseases / Matrix Metalloproteinase 3 / Tissue Inhibitor of Metalloproteinase-1 / Matrix Metalloproteinase 2 / Diabetes Mellitus, Type 1 / Matrix Metalloproteinase 10 Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Cardiovasc Diabetol Journal subject: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Year: 2015 Type: Article

Full text: 1 Database: MEDLINE Main subject: Vascular Diseases / Matrix Metalloproteinase 3 / Tissue Inhibitor of Metalloproteinase-1 / Matrix Metalloproteinase 2 / Diabetes Mellitus, Type 1 / Matrix Metalloproteinase 10 Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Cardiovasc Diabetol Journal subject: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Year: 2015 Type: Article